Completed

The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine on Marksmanship Accuracy and Reaction Time in ROTC Members, Military, and Law Enforcement Following a Mentally Fatiguing Protocol

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Caffeine+TeaCrine+Dynamine

+ Placebo

+ Caffeine

Drug
Who is being recruted

From 18 to 63 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Placebo-ControlledEarly Phase 1
Interventional
Study Start: May 2019
See protocol details

Summary

Principal SponsorUniversity of South Carolina
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 4, 2019

Actual date on which the first participant was enrolled.

BASELINE ASSESSMENT: * Subjects will report to the University of South Carolina Sport Science Lab normally hydrated and having refrained from eating for minimum 2 hours prior. * Upon arrival, subjects will complete the informed consent and the Caffeine Frequency Questionnaire (CFQ) to assess their intake. * Subjects will have body composition assessed using air displacement plethysmography (Bod Pod, Cosmed, Inc.) using standardized procedures. * A salivary sample will be provided by each subject before beginning familiarization to analyze for presence of the CYP1A2 (caffeine) gene. * Subjects will be familiarized with the cognitive testing protocols using the Dynavision D2TM board and TRAZER Sports Simulator. They will complete a shortened version of the mentally fatiguing condition on the DynavisionTM to familiarize with the protocol. They will be able to complete 3 trials of reaction time using the simulation on the TRAZER. * Following this, subjects will then complete 3 trials of marksmanship assessment using the optical targetry system. CONDITIONS: * Following exercise familiarization, subjects will be randomly assigned to the condition of placebo (P), caffeine (C), or combination of caffeine + TeaCrine + Dynamine (DC). Sessions will be scheduled at the same time as the initial baseline/familiarization session. * Subjects will be asked to maintain a normal sleep schedule in the week leading up to their session, maintaining the same wake time each day. * Subjects will be asked to refrain from alcohol for 48 hours and caffeine 24 hours prior to their condition, with no major changes in food intake. * Subjects will consume the supplement, complete the Multi-Component Training Distress Scale (MTDS) and will begin their session 30 minutes later. * Sessions will include 30 minutes of a mentally fatiguing task on the Dynavision D2TM board, designed with a go/no-go stimulus. The blinds will be drawn and lights switched off to reduce glare on the board. * At baseline and after each phase of the protocol, an assessment of psychological arousal will be taken using subjective measures of the Felt Arousal Scale (FAS) . * Subjects will then perform the reaction time assessment on the TRAZER and shooting assessment. This will be performed twice. The TRAZER will consist of 40 targets, and the shooting assessment will be 8 shots with a tactical re-load followed by an additional 8 shots. A 2-minute rest will be taken between trials. Total time allotted for assessments will be 20 minutes. * Subjects will then be seated in a room for 30 minutes, during which time they will read leisurely. At the completion of this time, subjects will complete the mentally fatiguing protocol once more (30 minutes). Following this, measures of reaction time and shooting assessment will be performed again (20 minutes). * Heart rate will be monitored and recorded throughout testing to establish average and peak values during the reaction time and marksmanship tasks. * Blood pressure will be measured pre- and post-testing using the Omron HEM 907XL Intellisense Pro Digital Blood Pressure cuff.

Official TitleThe Effects of a Combination of TeaCrine®, Dynamine, and Caffeine on Marksmanship Accuracy and Reaction Time in ROTC Members, Military, and Law Enforcement Following a Mentally Fatiguing Protocol
NCT03937687
Principal SponsorUniversity of South Carolina
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

49 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Male

Biological sex of participants that are eligible to enroll.

From 18 to 63 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

4 inclusion criteria required to participate
Subject has provided written and dated informed consent to participate in the study.

Subject is in good health as determined by physical examination and medical history.

Subject is between the ages of 18 and 63.

Subject is a current member of the military or law enforcement.

6 exclusion criteria prevent from participating
Subjects who have injuries that would prevent them from completing the protocol.

Subjects who have migraine headaches.

Subjects with a history of kidney or liver disease.

Subjects with a history of caffeine sensitivity.

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

33.333% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental
150 mg caffeine with 100 mg Dynamine and 50 mg TeaCrine

Group II

Placebo
300 mg cellulose

Group III

Experimental
300 mg caffeine

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Suspended

Rutgers University Center for Health and Human Performance

New Brunswick, United StatesOpen Rutgers University Center for Health and Human Performance in Google Maps
Suspended

University of South Carolina Sport Science Lab

Columbia, United States
Completed2 Study Centers